Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence
What Is the Growth Potential of the Ophthalmoplegia Market Size Over 2025-2034?
The ophthalmoplegia market size has grown strongly in recent years. It will grow from $1.68 billion in 2024 to $1.84 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to the increasing prevalence of neurological disorders, the growing aging population, the expansion of specialty clinics and hospitals, the rising demand for early diagnosis and treatment, the growing number of clinical trials, and the increase in healthcare insurance coverage.
The ophthalmoplegia market size is expected to see strong growth in the next few years. It will grow to " $2.7 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to the rising prevalence of neurological disorders, increasing aging population, growing awareness about eye movement disorders, increasing healthcare expenditure, increased investment in healthcare by key players, and growing patient population with diabetes and hypertension. Major trends in the forecast period include advancements in diagnostic technologies, development of novel therapeutic approaches, strategic collaborations and partnerships, technological advancements in eye tracking devices, and development of muscle-strengthening drugs.
Get your free report sample today:
What Are the Primary Factors Driving the Ophthalmoplegia Market?
The increasing incidence of neurological disorders is expected to propel the growth of the ophthalmoplegia market going forward. Neurological disorders refer to medical conditions that affect the nervous system, including the brain, spinal cord, and nerves, leading to symptoms such as muscle weakness, coordination issues, and cognitive impairments. The increasing incidence of neurological disorders is due to genetic predisposition, which makes individuals more susceptible to conditions such as Alzheimer's and Parkinson's, and lifestyle changes such as poor diet, sedentary behavior, and chronic stress, which contribute to neurodegeneration and impaired brain function. The ophthalmoplegia helps diagnose neurological disorders such as Alzheimer's disease, multiple sclerosis, and stroke by indicating impaired eye muscle control, which reflects underlying nervous system dysfunction. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, in 2023, about 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, with projections indicating an increase to 13.8 million by 2060. Therefore, the increasing incidence of neurological disorders is driving the growth of the ophthalmoplegia market.
Which Segments Are Likely to Shape the Future Outlook of the Ophthalmoplegia Market?
The ophthalmoplegiamarket covered in this report is segmented –
1) By Type: External Opthalmoplegia; Internuclear Opthalmoplegia
2) By Treatment: Surgery; Drug Treatment
3) By End-User: Hospitals; Clinics; Ambulatory Clinics
Subsegments:
1) By External Ophthalmoplegia: Chronic Progressive External Ophthalmoplegia (CPEO); Myasthenic External Ophthalmoplegia; Mitochondrial Myopathy-Associated External Ophthalmoplegia
2) By Internuclear Ophthalmoplegia: Unilateral Internuclear Ophthalmoplegia; Bilateral Internuclear Ophthalmoplegia
Which Key Players Dominate the Ophthalmoplegia Market Landscape?
Major companies operating in the ophthalmoplegia market are Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Medline Industries Inc., Regeneron Pharmaceuticals Inc., Carl Zeiss AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Bayer AG, Santen Pharmaceutical Co. Ltd., Oculis Holding AG, Innovative Pharmaceuticals Pvt. Ltd., Clearside Biomedical Inc., Altacor Limited, Azura Ophthalmics Ltd., ViGeneron GmbH, Amritt Inc., GenSight Biologics SA, EyeBio Inc., Opthea Limited
Get the detailed ophthalmoplegia market report today
Which Region Is Expected to Dominate the Ophthalmoplegia Market During the Forecast Period?
North America was the largest region in the ophthalmoplegia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmoplegia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment